Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/17963
Share/Export:
logo share SHARE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Title

Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine)

AuthorsPizarro, Nieves; Farré-Albaladejo, Magi; Pujadas, Mitona; Peiró, Ana María; Roset, Pere N.; Joglar Tamargo, Jesús CSIC ORCID; Torre, Rafael de la
Keywords3,4-Methylenedioxymethamphetamine
MDMA
Metabolites
3-methoxymethamphetamine
HMMA
Human samples
Elimination half-life
Issue DateSep-2004
PublisherAmerican Society for Pharmacology and Experimental Therapeutics
CitationDrug Metabolism and Disposition 32(9): 1001-1007 (2004)
Abstract3,4-Methylenedioxymethamphetamine (MDMA; "ecstasy") is a designer drug commonly misused in large segments of young populations. MDMA is usually formulated in tablets of its racemate (1:1 mixture of its enantiomers) in doses ranging from 50 to 200 mg. MDMA has an enantioselective metabolism, the (S)-enantiomer being metabolized faster than the (R)-enantiomer. Different pharmacologic properties have been attributed to each enantiomer. The carbon responsible for MDMA chirality is preserved along its metabolic disposition. An analytical method has been developed to determine MDMA enantiomers and those from its major metabolites, 3,4-methylenedioxyamphetamine (MDA), 3,4-dihydroxymeth-amphetamine (HHMA), and 4-hydroxy-3-methoxymethamphet-amine (HMMA). It has been applied to the analysis of plasma and urine samples from healthy recreational users of MDMA who participated voluntarily in a clinical trial and received 100 mg (R,S)-MDMA · HCl orally. (R)/(S) ratios both in plasma (0-48 h) and urine (0-72 h) for MDMA and MDA were >1 and <1, respectively. Ratios corresponding to HHMA and HMMA, close to unity, deviate from theoretical expectations and are most likely explained by the ability of MDMA to autoinhibit its own metabolism. The short elimination half-life of (S)-MDMA (4.8 h) is consistent with the subjective effects and psychomotor performance reported in subjects exposed to MDMA, whereas the much longer half-life of the (R)-enantiomer (14.8 h) correlates with mood and cognitive effects experienced on the next days after MDMA use.
Description7 pages, 2 figures, 2 tables.-- PMID: 15319342 [PubMed].
Publisher version (URL)http://dmd.aspetjournals.org/cgi/content/abstract/32/9/1001
URIhttp://hdl.handle.net/10261/17963
ISSN0090-9556 (Print)
1521-009X (Online)
Appears in Collections:(IQAC) Artículos

Show full item record
Review this work

Page view(s)

306
checked on May 18, 2022

Google ScholarTM

Check


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.